Sensei Biotherapeutics, Inc. (SNSE) has 97 open-market insider trades by 8 insiders since 2021. Over the last six months insiders net sold $1.0M. The most active filer is James Peyer, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Christian Angermayer | 10% Owner | — | 1 | $10.9M | 2023-06-01 |
| James Peyer | 10% Owner | — | 48 | $6.7M | 2026-06-01 |
| Cambrian BioPharma Inc via James Peyer | 10% Owner | — | 40 | $3.2M | 2026-06-01 |
| Millennium Management LLC | 10% Owner | — | 3 | $2.0M | 2026-04-07 |
| Robert Hamilton Pierce | CSO | — | 2 | $1.3M | 2022-02-15 |
| Thomas G. Ricks | Dir | — | 1 | $250K | 2023-07-10 |
| Apeiron Investment Group Ltd. | 10% | — | 1 | $4K | 2023-02-23 |
| John Celebi | Pres | — | 1 | $425 | 2025-02-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Cambrian BioPharma Inc | 10% Owner | Sell | $501K | 2026-06-01 |
| Millennium Management LLC | 10% Owner | Buy | $141K | 2026-04-02 |
| Millennium Management LLC | 10% Owner | Sell | $538K | 2026-04-02 |
| Millennium Management LLC | 10% Owner | Sell | $77K | 2026-03-31 |
| Millennium Management LLC | 10% Owner | Buy | $382K | 2026-03-31 |
| Millennium Management LLC | 10% Owner | Buy | $818K |
Companies that share insiders with SNSE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-03-26 |
| Millennium Management LLC | 10% Owner | Sell | $89K | 2026-03-26 |
| Cambrian BioPharma Inc | 10% | Sell | $55K | 2025-12-09 |
| James Peyer | 10% | Sell | $55K | 2025-12-08 |
| James Peyer | 10% Owner | Sell | $398K | 2025-12-04 |
| Cambrian BioPharma Inc | 10% | Sell | $233K | 2025-12-04 |
| John Celebi | President | Buy | $425 | 2023-09-11 |
| Christian Angermayer | 10% Owner | Sell | $10.9M | 2023-06-01 |
| Apeiron Investment Group Ltd. | 10% | Buy | $4K | 2023-02-23 |
| James Peyer | Director & 10% | Buy | $4K | 2022-03-02 |